AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/02/2024 | Press release | Distributed by Public on 05/02/2024 00:18
Please select the service you want to use:
Smartlinks | Pharmaniaga Bhd | News | Health | Company News | Shareholders | Shareholder Meeting | Proxy Statements | Securities Issuers | Pharmaceutical Companies | Bursa Malaysia (KLSE)
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact